@article{0edf11523ba149c19f1887f562af6031,
title = "Cerebrovascular pathology in cognitive impairment: New (in)sights",
author = "Knopman, {David S.}",
note = "Funding Information: Dr. Knopman serves as Deputy Editor for Neurology {\textregistered} ; serves on a data safety monitoring board for Eli Lilly and Company; is an investigator in clinical trials sponsored by Elan Corporation, Baxter International Inc., and Forest Laboratories, Inc.; and receives research support from the NIH. Funding Information: Study funding: Supported by NIH grants P50 AG16574, U01 AG06786, and R01 AG11378, and the Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation. ",
year = "2012",
month = apr,
day = "3",
doi = "10.1212/WNL.0b013e31824e8fb4",
language = "English (US)",
volume = "78",
pages = "1032--1033",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "14",
}